CLASS II Drug recall · Reported 13 Apr 2016 · FDA Enforcement Report

Formula 1 (Papaverine 1.8 mg, Phentolamine 0.2 mg recalled

Meditech Laboratories is recalling Formula 1 (Papaverine 1.8 mg, Phentolamine 0.2 mg, Atropine 0.02 mg, PGE 18 mcg/mL), distributed nationwide in the US. The recall was initiated on 14 Mar 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot#: 011916-1, Exp 04/19/16; 020316-1, Exp 05/03/16
Quantity recalled1320 vials - all formulas

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0805-2016
FDA event ID
73537
Recalling firm
Meditech Laboratories, Las Vegas, NV
Classification
Class II
Status
Terminated
Recall initiated
14 Mar 2016
FDA classified
1 Apr 2016
Reported
13 Apr 2016
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Potency & Assay

Timeline

14 Mar 2016Recall initiated by company
1 Apr 2016Classified by FDA+18 days
13 Apr 2016Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Formula 1 (Papaverine 1.8 mg, Phentolamine 0.2 mg, Atropine 0.02 mg, PGE 18 mcg/mL) Injection, 5 mL vial, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102.

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.

Which lots are affected?

Lot#: 011916-1, Exp 04/19/16; 020316-1, Exp 05/03/16

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

6 other products · FDA event 73537

This product is part of a recall event; the main page for the event is Formula 0 (PGE 20 mcg/mL) Injection vials recalled.

More recalls from Meditech Laboratories

All 7